Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. [electronic resource]
Producer: 20081204Description: 5233-9 p. digitalISSN:- 1527-7755
- Adolescent
- Adoptive Transfer
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cells, Cultured
- Chemotherapy, Adjuvant
- Child
- Cyclophosphamide -- administration & dosage
- Female
- Humans
- Interleukin-15 -- blood
- Interleukin-2 -- therapeutic use
- Interleukin-7 -- blood
- Kaplan-Meier Estimate
- Lymphocyte Depletion
- Lymphocytes, Tumor-Infiltrating -- immunology
- Male
- Melanoma -- drug therapy
- Middle Aged
- Myeloablative Agonists -- administration & dosage
- Neoadjuvant Therapy
- Neoplasm Metastasis
- Pilot Projects
- Radiotherapy Dosage
- Radiotherapy, Adjuvant
- Time Factors
- Treatment Outcome
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.